Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

<p>Figure S2. Nomogram for predicting progression-free survival (PFS) based on t.TRPC and disease volume score.</p>

Saved in:
Bibliographic Details
Main Author: Ruiliang Wang (17333340) (author)
Other Authors: Jing Xu (22749676) (author), Chenyi Zhu (22749679) (author), Wujianhong Liu (22749682) (author), Chengqi Jin (22749685) (author), Wentao Luo (22749688) (author), Tingting Zhao (17333385) (author), Changcheng Guo (17333361) (author), Wei Chen (22749691) (author), Bin Yang (17333400) (author)
Published: 2025
Subjects:
Cancer
Cancer Detection and Diagnosis
Methods and Technology
Biomarkers
Circulating tumor cells/DNA/exosomes
Genitourinary Cancers
Liquid Biopsy
Prostate Cancer
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items